Expansion Opportunity Resonetics is actively expanding facilities, including a planned Costa Rica multitenant building to support a third manufacturing plant and a headcount increase of 300, signaling growing capacity and regional footprint to capture additional medical device programs and faster time-to-market needs.

Strategic Acquisitions Recent acquisition activity includes acquiring Resolution Medical and integrating Med-Ally assets for implantable battery and neuromodulation manufacturing, creating a broader end-to-end solutions capability that can be cross-sold to neurovascular, neuromodulation, CRM, and BCI markets.

Integrated CDMO Strength As a vertically integrated CDMO with laser, nitinol, metal fabrication, and raw material capabilities plus centralized Lightspeed Development Lab, Resonetics positions itself to win complex, high-precision manufacturing programs from prototype to high-volume production.

Key Markets Strong focus on neurovascular, electrophysiology, ophthalmology, neuromodulation, structural heart, minimally invasive, and robotic surgery creates multiple cross-sell opportunities for existing customers and a pipeline for adjacent device categories requiring precision manufacturing and energy sources.

Global footprint With 20 facilities across North America, Europe, Israel, and beyond and ISO 13485:2016 certification, Resonetics offers scalable manufacturing partnerships and supply-chain resilience, enabling sales conversations around regional production capabilities and localized sourcing for global device programs.